Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Splenda® improves tolerance of oral potassium citrate supplementation for prevention of stone formation: results of a randomized double-blind trial.

Mechlin C, Kalorin C, Asplin J, White M. Splenda® improves tolerance of oral potassium citrate supplementation for prevention of stone formation: results of a randomized double-blind trial. J Endourol. 2011 Sep; 25(9):1541-5.

View in: PubMed

collapse authors with profiles